45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
4,971
Insurances with rates
9
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
177
$103,107
RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC
Gross
$114,563
602
$51,264
CELLULITIS WITH MCC
Gross
$56,960
560
$34,981
AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH CC
Gross
$38,867
949
$28,132
AFTERCARE WITH CC/MCC
Gross
$31,258
559
$27,251
AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MCC
Gross
$30,279
310
$27,236
CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT CC/MCC
Gross
$30,263
309
$27,231
CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH CC
Gross
$30,257
947
$26,955
SIGNS AND SYMPTOMS WITH MCC
Gross
$29,950
540
$25,490
OSTEOMYELITIS WITH CC
Gross
$28,322
314
$24,521
OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MCC
Gross
$27,246
638
$19,548
DIABETES WITH CC
Gross
$21,720
195
$19,485
SIMPLE PNEUMONIA AND PLEURISY WITHOUT CC/MCC
Gross
$21,650
06000092
$19,117
INJECTION, ALTEPLASE RECOMBINANT, 1 MG
Gross
$21,241
313
$18,724
CHEST PAIN
Gross
$20,804
06006669
$17,744
INJECTION, TENECTEPLASE, 1 MG
Gross
$19,716
561
$17,324
AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT CC/MCC
Gross
$19,249
536
$17,138
FRACTURES OF HIP AND PELVIS WITHOUT MCC
Gross
$19,042
303
$16,671
ATHEROSCLEROSIS WITHOUT MCC
Gross
$18,523
593
$15,924
SKIN ULCERS WITH CC
Gross
$17,693
689
$14,923
KIDNEY AND URINARY TRACT INFECTIONS WITH MCC
Gross
$16,581
06006417
$13,937
INJECTION, EFGARTIGIMOD ALFA-FCAB, 2MG
Gross
$15,486
637
$13,710
DIABETES WITH MCC
Gross
$15,234
202
$13,087
BRONCHITIS AND ASTHMA WITH CC/MCC
Gross
$14,541
914
$12,765
TRAUMATIC INJURY WITHOUT MCC
Gross
$14,183
06000127
$12,690
LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), 7.5 MG
Gross
$14,100
06005699
$11,652
INJECTION, BENRALIZUMAB, 1 MG
Gross
$12,947
872
$11,492
SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC
Gross
$12,769
153
$11,464
OTITIS MEDIA AND URI WITHOUT MCC
Gross
$12,738
292
$11,181
HEART FAILURE AND SHOCK WITH CC
Gross
$12,423
06005294
$10,579
INJECTION, RITUXIMAB, 10 MG
Gross
$11,754
06006330
$9,838
INJECTION, TEZEPELUMAB-EKKO, 1 MG
Gross
$10,931
06006615
$9,563
INJECTION, ALTEPLASE RECOMBINANT, 1 MG
Gross
$10,625
375
$9,352
DIGESTIVE MALIGNANCY WITH CC
Gross
$10,391
06001917
$9,345
INJECTION, PEGFILGRASTIM-JMDB (FULPHILA), BIOSIMILAR, 0.5 MG
Gross
$10,384
293
$9,338
HEART FAILURE AND SHOCK WITHOUT CC/MCC
Gross
$10,376
304
$8,989
HYPERTENSION WITH MCC
Gross
$9,987
281
$8,783
ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH CC
Gross
$9,759
682
$8,582
RENAL FAILURE WITH MCC
Gross
$9,536
06005167
$8,558
INJECTION, MEPOLIZUMAB, 1 MG
Gross
$9,509
06006250
$8,532
INJECTION, PEGFILGRASTIM-BMEZ (ZIEXTENZO), BIOSIMILAR, 0.5 MG
Gross
$9,480
06006633
$8,531
UNCLASSIFIED BIOLOGICS
Gross
$9,479
06005276
$8,507
INJECTION, OCTREOTIDE, DEPOT FORM FOR INTRAMUSCULAR INJECTION, 1 MG
Gross
$9,453
189
$8,267
PULMONARY EDEMA AND RESPIRATORY FAILURE
Gross
$9,185
204
$8,245
RESPIRATORY SIGNS AND SYMPTOMS
Gross
$9,162
440
$8,095
DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT CC/MCC
Gross
$8,995
377
$8,021
GASTROINTESTINAL HEMORRHAGE WITH MCC
Gross
$8,913
563
$8,021
FRACTURE, SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITHOUT MCC
Gross
$8,912
684
$7,821
RENAL FAILURE WITHOUT CC/MCC
Gross
$8,690
178
$7,612
RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH CC
Gross
$8,458
390
$7,494
GASTROINTESTINAL OBSTRUCTION WITHOUT CC/MCC
Gross
$8,327
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 177 | RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | $114,563 | $103,107 | — | — | 9 |
| 602 | CELLULITIS WITH MCC | $56,960 | $51,264 | — | — | 9 |
| 560 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH CC | $38,867 | $34,981 | — | — | 9 |
| 949 | AFTERCARE WITH CC/MCC | $31,258 | $28,132 | — | — | 6 |
| 559 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MCC | $30,279 | $27,251 | — | — | 9 |
| 310 | CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT CC/MCC | $30,263 | $27,236 | — | — | 9 |
| 309 | CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH CC | $30,257 | $27,231 | — | — | 9 |
| 947 | SIGNS AND SYMPTOMS WITH MCC | $29,950 | $26,955 | — | — | 9 |
| 540 | OSTEOMYELITIS WITH CC | $28,322 | $25,490 | — | — | 6 |
| 314 | OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MCC | $27,246 | $24,521 | — | — | 6 |
| 638 | DIABETES WITH CC | $21,720 | $19,548 | — | — | 9 |
| 195 | SIMPLE PNEUMONIA AND PLEURISY WITHOUT CC/MCC | $21,650 | $19,485 | — | — | 9 |
| 06000092 | INJECTION, ALTEPLASE RECOMBINANT, 1 MG | $21,241 | $19,117 | — | — | 9 |
| 313 | CHEST PAIN | $20,804 | $18,724 | — | — | 9 |
| 06006669 | INJECTION, TENECTEPLASE, 1 MG | $19,716 | $17,744 | — | — | 9 |
| 561 | AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT CC/MCC | $19,249 | $17,324 | — | — | 9 |
| 536 | FRACTURES OF HIP AND PELVIS WITHOUT MCC | $19,042 | $17,138 | — | — | 9 |
| 303 | ATHEROSCLEROSIS WITHOUT MCC | $18,523 | $16,671 | — | — | 9 |
| 593 | SKIN ULCERS WITH CC | $17,693 | $15,924 | — | — | 6 |
| 689 | KIDNEY AND URINARY TRACT INFECTIONS WITH MCC | $16,581 | $14,923 | — | — | 9 |
| 06006417 | INJECTION, EFGARTIGIMOD ALFA-FCAB, 2MG | $15,486 | $13,937 | — | — | 8 |
| 637 | DIABETES WITH MCC | $15,234 | $13,710 | — | — | 9 |
| 202 | BRONCHITIS AND ASTHMA WITH CC/MCC | $14,541 | $13,087 | — | — | 6 |
| 914 | TRAUMATIC INJURY WITHOUT MCC | $14,183 | $12,765 | — | — | 9 |
| 06000127 | LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), 7.5 MG | $14,100 | $12,690 | — | — | 9 |
| 06005699 | INJECTION, BENRALIZUMAB, 1 MG | $12,947 | $11,652 | — | — | 9 |
| 872 | SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | $12,769 | $11,492 | — | — | 9 |
| 153 | OTITIS MEDIA AND URI WITHOUT MCC | $12,738 | $11,464 | — | — | 9 |
| 292 | HEART FAILURE AND SHOCK WITH CC | $12,423 | $11,181 | — | — | 9 |
| 06005294 | INJECTION, RITUXIMAB, 10 MG | $11,754 | $10,579 | — | — | 9 |
| 06006330 | INJECTION, TEZEPELUMAB-EKKO, 1 MG | $10,931 | $9,838 | — | — | 8 |
| 06006615 | INJECTION, ALTEPLASE RECOMBINANT, 1 MG | $10,625 | $9,563 | — | — | 9 |
| 375 | DIGESTIVE MALIGNANCY WITH CC | $10,391 | $9,352 | — | — | 9 |
| 06001917 | INJECTION, PEGFILGRASTIM-JMDB (FULPHILA), BIOSIMILAR, 0.5 MG | $10,384 | $9,345 | — | — | 9 |
| 293 | HEART FAILURE AND SHOCK WITHOUT CC/MCC | $10,376 | $9,338 | — | — | 9 |
| 304 | HYPERTENSION WITH MCC | $9,987 | $8,989 | — | — | 9 |
| 281 | ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH CC | $9,759 | $8,783 | — | — | 9 |
| 682 | RENAL FAILURE WITH MCC | $9,536 | $8,582 | — | — | 9 |
| 06005167 | INJECTION, MEPOLIZUMAB, 1 MG | $9,509 | $8,558 | — | — | 9 |
| 06006250 | INJECTION, PEGFILGRASTIM-BMEZ (ZIEXTENZO), BIOSIMILAR, 0.5 MG | $9,480 | $8,532 | — | — | 9 |
| 06006633 | UNCLASSIFIED BIOLOGICS | $9,479 | $8,531 | — | — | 8 |
| 06005276 | INJECTION, OCTREOTIDE, DEPOT FORM FOR INTRAMUSCULAR INJECTION, 1 MG | $9,453 | $8,507 | — | — | 9 |
| 189 | PULMONARY EDEMA AND RESPIRATORY FAILURE | $9,185 | $8,267 | — | — | 9 |
| 204 | RESPIRATORY SIGNS AND SYMPTOMS | $9,162 | $8,245 | — | — | 9 |
| 440 | DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT CC/MCC | $8,995 | $8,095 | — | — | 9 |
| 377 | GASTROINTESTINAL HEMORRHAGE WITH MCC | $8,913 | $8,021 | — | — | 6 |
| 563 | FRACTURE, SPRAIN, STRAIN AND DISLOCATION EXCEPT FEMUR, HIP, PELVIS AND THIGH WITHOUT MCC | $8,912 | $8,021 | — | — | 9 |
| 684 | RENAL FAILURE WITHOUT CC/MCC | $8,690 | $7,821 | — | — | 9 |
| 178 | RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH CC | $8,458 | $7,612 | — | — | 9 |
| 390 | GASTROINTESTINAL OBSTRUCTION WITHOUT CC/MCC | $8,327 | $7,494 | — | — | 9 |
Showing top 50 of 4,971 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.